Global Market Report

Global Opioid-Induced Constipation (Oic) Treatment Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jan 19, 2019
  • PAGES：151
  • REPORT CODE：GMM154253
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Opioid-Induced Constipation (Oic) Treatment witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Opioid-Induced Constipation (Oic) Treatment market is offered. The research provides insights for the global Opioid-Induced Constipation (Oic) Treatment market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Opioid-Induced Constipation (Oic) Treatment industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Opioid-Induced Constipation (Oic) Treatment Market Segmentations:

    By Players:

    • Pfizer, Inc.,

    • AIKO Biotechnology,

    • Salix Pharmaceuticals, Inc.

    • Takeda Pharmaceutical Company Limited

    • Cubist Pharmaceuticals,

    • AstraZeneca plc, Inc.,

    • S.L.A. Pharma AG,

    • GlaxoSmithKline, Inc.,


    By Types:

    • Naloxegol

    • Lubiprostone

    • Methylnaltrexone Bromide

    • Docusate Sodium

    • Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)


    By End-User:

    • Oral

    • Parenteral (Subcutaneous Injection)


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Opioid-Induced Constipation (Oic) Treatment Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Opioid-Induced Constipation (Oic) Treatment Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid-Induced Constipation (Oic) Treatment Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Opioid-Induced Constipation (Oic) Treatment Market Share by Types

      • 1.3.2 Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Naloxegol from 2013 to 2025

      • 1.3.3 Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Lubiprostone from 2013 to 2025

      • 1.3.4 Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Methylnaltrexone Bromide from 2013 to 2025

      • 1.3.5 Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Docusate Sodium from 2013 to 2025

      • 1.3.6 Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs) from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Opioid-Induced Constipation (Oic) Treatment Market Share by End-Users

      • 1.4.2 Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Oral from 2013 to 2025

      • 1.4.3 Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Parenteral (Subcutaneous Injection) from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumOpioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Opioid-Induced Constipation (Oic) Treatment Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid-Induced Constipation (Oic) Treatment by Major Types

      • 3.4.1 Market Size and Growth Rate of Naloxegol

      • 3.4.2 Market Size and Growth Rate of Lubiprostone

      • 3.4.3 Market Size and Growth Rate of Methylnaltrexone Bromide

      • 3.4.4 Market Size and Growth Rate of Docusate Sodium

      • 3.4.5 Market Size and Growth Rate of Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)


    4 Segmentation of Opioid-Induced Constipation (Oic) Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid-Induced Constipation (Oic) Treatment by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioid-Induced Constipation (Oic) Treatment for Oral

      • 4.4.2 Market Size and Growth Rate of Opioid-Induced Constipation (Oic) Treatment for Parenteral (Subcutaneous Injection)


    5 Market Analysis by Major Regions

    • 5.1 Global Opioid-Induced Constipation (Oic) Treatment Production Analysis by Major Regions

    • 5.2 Global Opioid-Induced Constipation (Oic) Treatment Consumption Analysis by Major Regions

    • 5.3 Global Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis


    6 Product Commodity of Opioid-Induced Constipation (Oic) Treatment Market in Major Countries

    • 6.1 Top 5 Export Countries in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Opioid-Induced Constipation (Oic) Treatment Landscape Analysis

    • 7.1 North America Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Types

    • 7.2 North America Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major End-Users

    • 7.3 North America Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Countries

      • 7.3.1 United States Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 7.3.2 Canada Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 7.3.3 Mexico Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate


    8 Europe Opioid-Induced Constipation (Oic) Treatment Landscape Analysis

    • 8.1 Europe Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Types

    • 8.2 Europe Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major End-Users

    • 8.3 Europe Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Countries

      • 8.3.1 Germany Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.2 UK Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.3 France Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.4 Italy Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.6 Spain Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.7 Belgium Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.8 Poland Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.9 Russia Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 8.3.10 Turkey Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate


    9 Asia Pacific Opioid-Induced Constipation (Oic) Treatment Landscape Analysis

    • 9.1 Asia Pacific Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Types

    • 9.2 Asia Pacific Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Countries

      • 9.3.1 China Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 9.3.2 Japan Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 9.3.4 India Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 9.3.6 South Korea Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 10.3.2 Brazil Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 10.3.3 Nigeria Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

      • 10.3.4 South Africa Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate 

      • 10.3.5 Argentina Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Pfizer, Inc.,

      • 11.1.1 Pfizer, Inc., Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 AIKO Biotechnology,

      • 11.2.1 AIKO Biotechnology, Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Salix Pharmaceuticals, Inc.

      • 11.3.1 Salix Pharmaceuticals, Inc. Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Takeda Pharmaceutical Company Limited

      • 11.4.1 Takeda Pharmaceutical Company Limited Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Cubist Pharmaceuticals,

      • 11.5.1 Cubist Pharmaceuticals, Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 AstraZeneca plc, Inc.,

      • 11.6.1 AstraZeneca plc, Inc., Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 S.L.A. Pharma AG,

      • 11.7.1 S.L.A. Pharma AG, Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 GlaxoSmithKline, Inc.,

      • 11.8.1 GlaxoSmithKline, Inc., Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 85 Figures and 154 Tables)

    • Figure Product Picture

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Naloxegol from 2013 to 2025

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Lubiprostone from 2013 to 2025

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Methylnaltrexone Bromide from 2013 to 2025

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Docusate Sodium from 2013 to 2025

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs) from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Oral from 2013 to 2025

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Market Size and Growth Rate of Parenteral (Subcutaneous Injection) from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Opioid-Induced Constipation (Oic) Treatment Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Opioid-Induced Constipation (Oic) Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioid-Induced Constipation (Oic) Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid-Induced Constipation (Oic) Treatment by Different Types from 2013 to 2025

    • Table Consumption Share of Opioid-Induced Constipation (Oic) Treatment by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of Naloxegol

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Methylnaltrexone Bromide

    • Figure Market Size and Growth Rate of Docusate Sodium

    • Figure Market Size and Growth Rate of Others (Osmotic laxatives, Emollient or lubricant cathartics, Bulk cathartics, Stimulant cathartics, Prostaglandins or prokinetic drugs)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioid-Induced Constipation (Oic) Treatment by Different End-Users from 2013 to 2025

    • Table Consumption Share of Opioid-Induced Constipation (Oic) Treatment by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Parenteral (Subcutaneous Injection)

    • Table Global Opioid-Induced Constipation (Oic) Treatment Production by Major Regions

    • Table Global Opioid-Induced Constipation (Oic) Treatment Production Share by Major Regions

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Production Share by Major Regions in 2013

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Production Share by Major Regions in 2018

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Production Share by Major Regions in 2025

    • Table Global Opioid-Induced Constipation (Oic) Treatment Consumption by Major Regions

    • Table Global Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Regions

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Regions in 2013

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Regions in 2018

    • Figure Global Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Regions in 2025

    • Table North America Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis

    • Table Europe Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Opioid-Induced Constipation (Oic) Treatment market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Opioid-Induced Constipation (Oic) Treatment Consumption by Types from 2013 to 2025

    • Table North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types from 2013 to 2025

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2013

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2018

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2025

    • Table North America Opioid-Induced Constipation (Oic) Treatment Consumption by End-Users from 2013 to 2025

    • Table North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users from 2013 to 2025

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2013

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2018

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2025

    • Table North America Opioid-Induced Constipation (Oic) Treatment Consumption by Major Countries from 2013 to 2025

    • Table North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2013

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2018

    • Figure North America Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2025

    • Figure United States Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Opioid-Induced Constipation (Oic) Treatment Consumption by Types from 2013 to 2025

    • Table Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types from 2013 to 2025

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2013

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2018

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2025

    • Table Europe Opioid-Induced Constipation (Oic) Treatment Consumption by End-Users from 2013 to 2025

    • Table Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2013

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2018

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2025

    • Table Europe Opioid-Induced Constipation (Oic) Treatment Consumption by Major Countries from 2013 to 2025

    • Table Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2013

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2018

    • Figure Europe Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2025

    • Figure Germany Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure France Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption by Types from 2013 to 2025

    • Table Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2013

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2018

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2025

    • Table Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2013

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2018

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2025

    • Table Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2025

    • Figure China Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandOpioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure India Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Opioid-Induced Constipation (Oic) Treatment Consumption Share by Major Countries in 2025

    • Figure GCC Countries Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Opioid-Induced Constipation (Oic) Treatment Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of Pfizer, Inc.,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc.,

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc.,

    • Figure Revenue and Market Share Analysis of Pfizer, Inc.,

    • Table Product and Service Introduction of Pfizer, Inc.,

    • Table Company Profile and Development Status of AIKO Biotechnology,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AIKO Biotechnology,

    • Figure Sales and Growth Rate Analysis of AIKO Biotechnology,

    • Figure Revenue and Market Share Analysis of AIKO Biotechnology,

    • Table Product and Service Introduction of AIKO Biotechnology,

    • Table Company Profile and Development Status of Salix Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Salix Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

    • Table Company Profile and Development Status of Cubist Pharmaceuticals,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cubist Pharmaceuticals,

    • Figure Sales and Growth Rate Analysis of Cubist Pharmaceuticals,

    • Figure Revenue and Market Share Analysis of Cubist Pharmaceuticals,

    • Table Product and Service Introduction of Cubist Pharmaceuticals,

    • Table Company Profile and Development Status of AstraZeneca plc, Inc.,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc, Inc.,

    • Figure Sales and Growth Rate Analysis of AstraZeneca plc, Inc.,

    • Figure Revenue and Market Share Analysis of AstraZeneca plc, Inc.,

    • Table Product and Service Introduction of AstraZeneca plc, Inc.,

    • Table Company Profile and Development Status of S.L.A. Pharma AG,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of S.L.A. Pharma AG,

    • Figure Sales and Growth Rate Analysis of S.L.A. Pharma AG,

    • Figure Revenue and Market Share Analysis of S.L.A. Pharma AG,

    • Table Product and Service Introduction of S.L.A. Pharma AG,

    • Table Company Profile and Development Status of GlaxoSmithKline, Inc.,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline, Inc.,

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline, Inc.,

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline, Inc.,

    • Table Product and Service Introduction of GlaxoSmithKline, Inc.,


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US